The Affordable Care Act accelerated a movement away from traditional fee-for-service payments for medicine. New models of payment are being developed that shift risk to the providers of care for both the costs and quality of care provided. Many of these models were initially developed for primary care or common surgical procedures, but are now being developed and used for patients with hematologic diseases.

This program will address some of the challenges posed by attempting to create payment models for hematologic conditions, review studies of the utilization of hematologic services, and evaluate how these models are being implemented by insurers.